Compare HCSG & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | ABCL |
|---|---|---|
| Founded | 1976 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1994 | 2020 |
| Metric | HCSG | ABCL |
|---|---|---|
| Price | $18.35 | $3.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $19.83 | $7.75 |
| AVG Volume (30 Days) | 540.2K | ★ 2.3M |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.83 | 10.91 |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $1,837,173,000.00 | $75,128,000.00 |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $5.22 | $25.44 |
| P/E Ratio | $22.65 | ★ N/A |
| Revenue Growth | 7.08 | ★ 160.56 |
| 52 Week Low | $9.13 | $1.89 |
| 52 Week High | $22.98 | $6.52 |
| Indicator | HCSG | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 39.10 | 53.38 |
| Support Level | $18.28 | $3.37 |
| Resistance Level | $19.80 | $3.57 |
| Average True Range (ATR) | 0.73 | 0.15 |
| MACD | -0.15 | 0.01 |
| Stochastic Oscillator | 32.16 | 65.63 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.